Former Starbucks CEO Howard Schultz recently provided insight on the coffee chain’s recent struggles, emphasizing the importance of improving the company’s U.S. stores. Schultz highlighted the need for enhancing the mobile order and pay experience, as well as focusing on premium drink offerings to set Starbucks apart from competitors. He stressed the importance of prioritizing
Business
Amgen’s stock experienced a significant rise of over 12% on Friday following the release of positive initial data on its new weight loss injection, MariTide. This announcement stirred investor concerns about potential competition in the rapidly expanding weight loss drug market, subsequently causing shares of current industry players such as Novo Nordisk and Eli Lilly
Carvana, the online auto retailer, experienced a significant surge of over 30% in after-hours trading following their first quarter report, which showcased record-breaking results and profitability. The company’s earnings per share came in at 23 cents, far exceeding the expected loss of 74 cents, while their revenue of $3.06 billion surpassed the anticipated $2.67 billion.
CVS Health recently reported first-quarter revenue and adjusted earnings that fell short of expectations, leading to a significant drop in share price. The company cut its full-year profit forecast due to higher medical costs impacting the U.S. insurance industry. The main factor contributing to this setback is increased pressure on medical costs within CVS’s insurance
Johnson & Johnson recently announced its plan to pay $6.5 billion over 25 years to settle the majority of lawsuits in the U.S. claiming that its talc-based products led to ovarian cancer. This move is seen as a significant step towards resolving legal issues that have plagued the company for decades. The company contends that
In a bid to bring back the iconic “Roundball Rock” theme song to the National Basketball Association (NBA) games, NBCUniversal has made an offer that averages $2.5 billion per year to acquire NBA rights. The bid comes after NBC lost the rights to Disney 22 years ago and now seeks to once again be part
In a move that echoes a storyline straight out of a drama series, Paramount Global is gearing up to replace its Chief Executive Officer, Bob Bakish, with a group of current division heads. The decision, set to be announced on Monday, is poised to set a new course for the company’s future. The timing of
The recent approval by the Food and Drug Administration of Pfizer’s new gene therapy, Beqvez, marks a significant milestone in the treatment of hemophilia B, a rare genetic bleeding disorder. This treatment is set to revolutionize the way patients with moderate to severe hemophilia B manage their condition. Hemophilia B is characterized by insufficient levels
Southwest Airlines recently reported a wider loss for the first quarter of the year compared to the same period last year. The airline also expressed concerns about Boeing’s aircraft delays hindering its growth until 2025. Due to these challenges, Southwest has revised its capacity growth plans, expecting to grow by only 4% this year instead
Walgreens recently announced a new initiative to directly collaborate with drug manufacturers in bringing cell and gene therapies to patients in the United States. The company revealed plans to set up a new business unit solely focused on expanding its specialty pharmacy services. This move signifies Walgreens’ commitment to catering to the rising demand for
